Ruxience

E261831 UNEXPLORED

Ruxience is a biosimilar monoclonal antibody to rituximab used in the treatment of certain cancers and autoimmune diseases.


Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

Rituxan hasBiosimilar Ruxience